Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 432

1.

The potential role of thiamine (vitamin B1) in diabetic complications.

Thornalley PJ.

Curr Diabetes Rev. 2005 Aug;1(3):287-98. Review.

PMID:
18220605
2.

Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine.

Babaei-Jadidi R, Karachalias N, Ahmed N, Battah S, Thornalley PJ.

Diabetes. 2003 Aug;52(8):2110-20.

3.

High-dose thiamine therapy counters dyslipidemia and advanced glycation of plasma protein in streptozotocin-induced diabetic rats.

Karachalias N, Babaei-Jadidi R, Kupich C, Ahmed N, Thornalley PJ.

Ann N Y Acad Sci. 2005 Jun;1043:777-83.

PMID:
16037305
4.

Regulation of intracellular glucose and polyol pathway by thiamine and benfotiamine in vascular cells cultured in high glucose.

Berrone E, Beltramo E, Solimine C, Ape AU, Porta M.

J Biol Chem. 2006 Apr 7;281(14):9307-13. Epub 2006 Feb 1.

6.

Emerging role of thiamine therapy for prevention and treatment of early-stage diabetic nephropathy.

Rabbani N, Thornalley PJ.

Diabetes Obes Metab. 2011 Jul;13(7):577-83. doi: 10.1111/j.1463-1326.2011.01384.x. Review.

PMID:
21342411
7.

Effects of thiamine and benfotiamine on intracellular glucose metabolism and relevance in the prevention of diabetic complications.

Beltramo E, Berrone E, Tarallo S, Porta M.

Acta Diabetol. 2008 Sep;45(3):131-41. doi: 10.1007/s00592-008-0042-y. Epub 2008 Jun 26. Review.

PMID:
18581039
8.

Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy.

Hammes HP, Du X, Edelstein D, Taguchi T, Matsumura T, Ju Q, Lin J, Bierhaus A, Nawroth P, Hannak D, Neumaier M, Bergfeld R, Giardino I, Brownlee M.

Nat Med. 2003 Mar;9(3):294-9. Epub 2003 Feb 18.

PMID:
12592403
9.

Vitamin B1 blocks damage caused by hyperglycemia.

Obrenovich ME, Monnier VM.

Sci Aging Knowledge Environ. 2003 Mar 12;2003(10):PE6.

PMID:
12844520
10.

Prevention of incipient diabetic cardiomyopathy by high-dose thiamine.

Kohda Y, Shirakawa H, Yamane K, Otsuka K, Kono T, Terasaki F, Tanaka T.

J Toxicol Sci. 2008 Oct;33(4):459-72.

11.

Ameliorative effect of combination of benfotiamine and fenofibrate in diabetes-induced vascular endothelial dysfunction and nephropathy in the rat.

Balakumar P, Chakkarwar VA, Singh M.

Mol Cell Biochem. 2009 Jan;320(1-2):149-62. doi: 10.1007/s11010-008-9917-z. Epub 2008 Oct 2.

PMID:
18830571
12.

Could thiamine pyrophosphate be a regulator of the nitric oxide synthesis in the endothelial cell of diabetic patients?

Alcázar-Leyva S, Alvarado-Vásquez N.

Med Hypotheses. 2011 May;76(5):629-31. doi: 10.1016/j.mehy.2011.01.015. Epub 2011 Feb 1.

PMID:
21288652
13.

Thiamine and benfotiamine prevent increased apoptosis in endothelial cells and pericytes cultured in high glucose.

Beltramo E, Berrone E, Buttiglieri S, Porta M.

Diabetes Metab Res Rev. 2004 Jul-Aug;20(4):330-6.

PMID:
15250036
14.

Benfotiamine exhibits direct antioxidative capacity and prevents induction of DNA damage in vitro.

Schmid U, Stopper H, Heidland A, Schupp N.

Diabetes Metab Res Rev. 2008 Jul-Aug;24(5):371-7. doi: 10.1002/dmrr.860.

PMID:
18384109
15.

Thiamine deficiency in diabetes mellitus and the impact of thiamine replacement on glucose metabolism and vascular disease.

Page GL, Laight D, Cummings MH.

Int J Clin Pract. 2011 Jun;65(6):684-90. doi: 10.1111/j.1742-1241.2011.02680.x. Review.

PMID:
21564442
16.

Different apoptotic responses of human and bovine pericytes to fluctuating glucose levels and protective role of thiamine.

Beltramo E, Berrone E, Tarallo S, Porta M.

Diabetes Metab Res Rev. 2009 Sep;25(6):566-76. doi: 10.1002/dmrr.996.

PMID:
19593734
17.

Activation of the hexosamine pathway causes oxidative stress and abnormal embryo gene expression: involvement in diabetic teratogenesis.

Horal M, Zhang Z, Stanton R, Virkamäki A, Loeken MR.

Birth Defects Res A Clin Mol Teratol. 2004 Aug;70(8):519-27.

PMID:
15329829
18.

Benfotiamine is similar to thiamine in correcting endothelial cell defects induced by high glucose.

Pomero F, Molinar Min A, La Selva M, Allione A, Molinatti GM, Porta M.

Acta Diabetol. 2001;38(3):135-8.

PMID:
11827434
19.

High-dose thiamine therapy counters dyslipidaemia in streptozotocin-induced diabetic rats.

Babaei-Jadidi R, Karachalias N, Kupich C, Ahmed N, Thornalley PJ.

Diabetologia. 2004 Dec;47(12):2235-46. Epub 2004 Dec 11.

PMID:
15662560
20.

[Prophylactic and therapeutic application of thiamine (vitamin B1)--a new point of view].

Małecka SA, Poprawski K, Bilski B.

Wiad Lek. 2006;59(5-6):383-7. Review. Polish.

PMID:
17017487

Supplemental Content

Support Center